The Role of MicroRNAs in HER2-Positive Breast Cancer: Where We Are and Future Prospective

SIMPLE SUMMARY: Breast cancer is the most diagnosed malignancy in woman worldwide and, despite the availability of new innovative therapies, it remains the first cause of death for tumor in woman. 20% of all breast cancer cases are HER2 positive, meaning that they are characterized by an aberrant ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Fogazzi, Valentina, Kapahnke, Marcel, Cataldo, Alessandra, Plantamura, Ilaria, Tagliabue, Elda, Di Cosimo, Serena, Cosentino, Giulia, Iorio, Marilena V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657949/
https://www.ncbi.nlm.nih.gov/pubmed/36358746
http://dx.doi.org/10.3390/cancers14215326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657949/
https://www.ncbi.nlm.nih.gov/pubmed/36358746
http://dx.doi.org/10.3390/cancers14215326

Ejemplares similares